NCT06975059 Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
| NCT ID | NCT06975059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Parkinson's Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-30 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.
Eligibility Criteria
Parkinson's Disease: Inclusion Criteria: 1. Male or female ≥ 18 years of age. 2. A diagnosis of Parkinson's disease 3. Able to give written informed consent (as determined by the investigator) 4. Can converse in English and read and perform all study activities 5. Has willingness and ability to comply with study requirements Exclusion Criteria: 1. Diagnosis of an atypical parkinsonism syndrome, drug-induced parkinsonism, essential tremor, or other diagnoses that explain movement symptoms other than PD 2. A diagnosis of significant CNS disease other than PD such as stroke, multiple sclerosis, epilepsy 3. Persons with disorders other than PD significantly affecting gait as determined by the investigator 4. History of MRI brain scan indicative of clinically significant abnormality as determined by the investigator 5. Inability to wear interventional device 6. Unable to ambulate independently at least with assistive walking device but without additional person assistance 7. Pregnant or planning pregnancy within study timeframe 8. Montreal Cognitive Assessment (MoCA) score \< 22 at screening 9. Resides in a nursing home or assisted care facility Healthy Controls: Inclusion Criteria: 1. Male or female ≥ 18 years of age. 2. No neurological disease or other significant gait impairment as deemed by the study investigator
Contact & Investigator
Harini Sarva, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT06975059 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06975059 currently recruiting?
Yes, NCT06975059 is actively recruiting participants. Contact the research team at has9059@med.cornell.edu for enrollment information.
Where is the NCT06975059 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06975059 clinical trial?
NCT06975059 is sponsored by Weill Medical College of Cornell University. The principal investigator is Harini Sarva, MD at Weill Medical College of Cornell University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.